Rakesh K Jain

Sitert av

	Alle	Siden 2020
Sitater	246019	76997
h-indeks	229	133
i10-indeks	665	482

17000

8500

4250

12750

199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025952 1192 1677 1792 1768 2445 3046 3511 3782 4818 5764 6324 6977 7328 8174 9502 10629 11194 11801 11716 11970 12058 12399 12492 14735 16479 15956 14105 13344 2321

Offentlig tilgang

Vis alle

281 artikler

7 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Dan G. Duda, DMD, PhDProfessor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical SchoolVerifisert e-postadresse på partners.org
Lance MunnHarvard Medical SchoolVerifisert e-postadresse på steele.mgh.harvard.edu
Emmanuelle di TomasoHarvard, UCL, Scripps, Novartis, Syros, BayerVerifisert e-postadresse på bayer.com
Triantafyllos StylianopoulosAssociate Professor of Mechanical Engineering, Cancer Biophysics Lab, University of CyprusVerifisert e-postadresse på ucy.ac.cy
Fan YuanDepartment of Biomedical Engineering, Duke University, Durham, NC 27708Verifisert e-postadresse på duke.edu
Moungi G. BawendiMassachusetts Institute of TechnologyVerifisert e-postadresse på mit.edu
A. Gregory SorensenDeepHealth, Inc.Verifisert e-postadresse på deep.health
Peter Carmeliethoogleraar, Universiteit van Leuven, VIBVerifisert e-postadresse på kuleuven.vib.be
David Alan BerkSenior Lecturer in Pharmacokinetics & Drug DeliveryVerifisert e-postadresse på alumni.duke.edu
John MartinMateria TherapeuticsVerifisert e-postadresse på mit.edu
Vikash P. ChauhanLSRF Postdoctoral Fellow, MITVerifisert e-postadresse på mit.edu
Walid KamounTakedaVerifisert e-postadresse på takeda.com
Patrick WenProfessor of Neurology, Harvard Medical SchoolVerifisert e-postadresse på dfci.harvard.edu
Paolo NettiIstituto Italiano di tecnologia (IIT) and University of Naples Federico IIVerifisert e-postadresse på unina.it

Følg

Rakesh K Jain

Andre navnRakesh Jain

Massachusetts General Hospital, Harvard Medical School, Carnegie Mellon, Columbia, Delaware

Verifisert e-postadresse på steele.mgh.harvard.edu - Startside


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Angiogenesis in cancer and other diseases P Carmeliet, RK Jain nature 407 (6801), 249-257, 2000	12138	2000
Photodynamic therapy for cancer DE Dolmans, D Fukumura, RK Jain Nature reviews cancer 3 (5), 380-387, 2003	7675	2003
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy RK Jain Science 307 (5706), 58-62, 2005	6657	2005
Molecular mechanisms and clinical applications of angiogenesis P Carmeliet, RK Jain Nature 473 (7347), 298-307, 2011	6348	2011
Understanding the tumor immune microenvironment (TIME) for effective therapy M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ... Nature medicine 24 (5), 541-550, 2018	4745	2018
Delivering nanomedicine to solid tumors RK Jain, T Stylianopoulos Nature reviews Clinical oncology 7 (11), 653-664, 2010	3617	2010
Molecular regulation of vessel maturation RK Jain Nature medicine 9 (6), 685-693, 2003	3456	2003
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ... Nature 394 (6692), 485-490, 1998	3445	1998
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment SK Hobbs, WL Monsky, F Yuan, WG Roberts, L Griffith, VP Torchilin, ... Proceedings of the National Academy of Sciences 95 (8), 4607-4612, 1998	3070	1998
A framework for advancing our understanding of cancer-associated fibroblasts E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ... Nature Reviews Cancer 20 (3), 174-186, 2020	3019	2020
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy RK Jain Nature medicine 7 (9), 987-989, 2001	2748	2001
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ... Nature medicine 10 (2), 145-147, 2004	2515	2004
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size F Yuan, M Dellian, D Fukumura, M Leunig, DA Berk, VP Torchilin, RK Jain Cancer research 55 (17), 3752-3756, 1995	2325	1995
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007	2133	2007
Openings between defective endothelial cells explain tumor vessel leakiness H Hashizume, P Baluk, S Morikawa, JW McLean, G Thurston, S Roberge, ... The American journal of pathology 156 (4), 1363-1380, 2000	2115	2000
Interstitial pH and pO₂ gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation G Helmlinger, F Yuan, M Dellian, RK Jain Nature medicine 3 (2), 177-182, 1997	2043	1997
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020	1954	2020
Transport of molecules in the tumor interstitium: a review RK Jain Cancer research 47 (12), 3039-3051, 1987	1949	1987
Determinants of tumor blood flow: a review RK Jain Cancer research 48 (10), 2641-2658, 1988	1935	1988
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases P Carmeliet, RK Jain Nature reviews Drug discovery 10 (6), 417-427, 2011	1898	2011

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere